These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Screening for sickle cell disease in newborns: a systematic review. Runkel B; Klüppelholz B; Rummer A; Sieben W; Lampert U; Bollig C; Markes M; Paschen U; Angelescu K Syst Rev; 2020 Oct; 9(1):250. PubMed ID: 33126922 [TBL] [Abstract][Full Text] [Related]
5. Fifteen years of newborn sickle cell disease screening in Madrid, Spain: an emerging disease in a European country. García-Morín M; Bardón-Cancho EJ; Beléndez C; Zamarro R; Béliz-Mendiola C; González-Rivera M; Vecilla C; Llorente-Otones L; Pérez-Alonso V; Román SS; Sebastián E; Dulín E; Cela E Ann Hematol; 2020 Jul; 99(7):1465-1474. PubMed ID: 32451712 [TBL] [Abstract][Full Text] [Related]
6. [Neonatal screening of hemoglobinopathies and G6PD deficiency in Catalonia (Spain). Molecular study of sickle cell disease associated with alpha thalassemia and G6PD deficiency]. Mañú Pereira Mdel M; Cabot A; Martínez González A; Sitjà Navarro E; Cararach V; Sabrià J; Boixaderas J; Teixidor R; Bosch A; López Vílchez MA; Martín Ibáñez I; Carrión T; Plaja P; Sánchez M; Vives Corrons JL Med Clin (Barc); 2007 Jun; 129(5):161-4. PubMed ID: 17669331 [TBL] [Abstract][Full Text] [Related]
7. Significant prevalence of sickle cell disease in Southwest Germany: results from a birth cohort study indicate the necessity for newborn screening. Kunz JB; Awad S; Happich M; Muckenthaler L; Lindner M; Gramer G; Okun JG; Hoffmann GF; Bruckner T; Muckenthaler MU; Kulozik AE Ann Hematol; 2016 Feb; 95(3):397-402. PubMed ID: 26658910 [TBL] [Abstract][Full Text] [Related]
10. Current challenges in the management of patients with sickle cell disease - A report of the Italian experience. Russo G; De Franceschi L; Colombatti R; Rigano P; Perrotta S; Voi V; Palazzi G; Fidone C; Quota A; Graziadei G; Pietrangelo A; Pinto V; Ruffo GB; Sorrentino F; Venturelli D; Casale M; Ferrara F; Sainati L; Cappellini MD; Piga A; Maggio A; Forni GL Orphanet J Rare Dis; 2019 May; 14(1):120. PubMed ID: 31146777 [TBL] [Abstract][Full Text] [Related]
11. [Neonatal screening of sickle cell disease in the Balearic Islands Autonomous Community. Pilot study in anonymous unrelated population]. López-Escribano H; Vila Vidal M; Barceló Bennassar A; Riesco Prieto M; Ayllón Gatnau O An Pediatr (Barc); 2009 May; 70(5):429-33. PubMed ID: 19376755 [TBL] [Abstract][Full Text] [Related]
12. The protective effect of the spleen in sickle cell patients. A comparative study between patients with asplenia/hyposplenism and hypersplenism. Peretz S; Livshits L; Pretorius E; Makhro A; Bogdanova A; Gassmann M; Koren A; Levin C Front Physiol; 2022; 13():796837. PubMed ID: 36105295 [TBL] [Abstract][Full Text] [Related]
13. Modeling the public health impact of voxelotor in the management of sickle cell disease in France. Galacteros F; Ethgen O; Beillat M PLoS One; 2023; 18(9):e0291211. PubMed ID: 37703228 [TBL] [Abstract][Full Text] [Related]
14. Incidence of sickle cell disease and other hemoglobin variants in 10,095 Lebanese neonates. Khoriaty E; Halaby R; Berro M; Sweid A; Abbas HA; Inati A PLoS One; 2014; 9(9):e105109. PubMed ID: 25180595 [TBL] [Abstract][Full Text] [Related]
16. The Red Blood Cell-Inflammation Vicious Circle in Sickle Cell Disease. Nader E; Romana M; Connes P Front Immunol; 2020; 11():454. PubMed ID: 32231672 [TBL] [Abstract][Full Text] [Related]